Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 583

1.

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Rabinowits G, Lezcano C, Catalano PJ, McHugh P, Becker H, Reilly MM, Huang J, Tyagi A, Thakuria M, Bresler SC, Sholl LM, Shapiro GI, Haddad R, DeCaprio JA.

Oncologist. 2018 Feb 14. pii: theoncologist.2017-0552. doi: 10.1634/theoncologist.2017-0552. [Epub ahead of print]

PMID:
29445030
2.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.

PMID:
29420467
3.

Age modifies the association between serum obestatin, appetite and nutritional status in maintenance hemodialysis patients.

Katkov A, Sinuani I, Azar A, Shapiro G, Efrati S, Beberashvili I.

Eur J Clin Nutr. 2018 Jan 23. doi: 10.1038/s41430-018-0087-0. [Epub ahead of print]

PMID:
29362457
4.

Knowledge and Attitudes of General Practitioners and Sexual Health Care Professionals Regarding Human Papillomavirus Vaccination for Young Men Who Have Sex with Men.

Merriel SWD, Flannagan C, Kesten JM, Shapiro GK, Nadarzynski T, Prue G.

Int J Environ Res Public Health. 2018 Jan 18;15(1). pii: E151. doi: 10.3390/ijerph15010151.

5.

The vaccine hesitancy scale: Psychometric properties and validation.

Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z.

Vaccine. 2018 Jan 29;36(5):660-667. doi: 10.1016/j.vaccine.2017.12.043. Epub 2017 Dec 27.

PMID:
29289384
6.

Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma.

Drew AE, Moradei O, Jacques SL, Rioux N, Boriack-Sjodin AP, Allain C, Scott MP, Jin L, Raimondi A, Handler JL, Ott HM, Kruger RG, McCabe MT, Sneeringer C, Riera T, Shapiro G, Waters NJ, Mitchell LH, Duncan KW, Moyer MP, Copeland RA, Smith J, Chesworth R, Ribich SA.

Sci Rep. 2017 Dec 21;7(1):17993. doi: 10.1038/s41598-017-18446-z.

7.

Ketamine in the Prehospital Environment: A National Survey of Paramedics in the United States.

Buckland DM, Crowe RP, Cash RE, Gondek S, Maluso P, Sirajuddin S, Smith ER, Dangerfield P, Shapiro G, Wanka C, Panchal AR, Sarani B.

Prehosp Disaster Med. 2018 Feb;33(1):23-28. doi: 10.1017/S1049023X17007142. Epub 2017 Dec 21.

PMID:
29265995
8.

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.

Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT.

Cancer Discov. 2018 Feb;8(2):184-195. doi: 10.1158/2159-8290.CD-17-1119. Epub 2017 Dec 15.

PMID:
29247021
9.

Associations between maternal triclosan concentrations in early pregnancy and gestational diabetes mellitus, impaired glucose tolerance, gestational weight gain and fetal markers of metabolic function.

Shapiro GD, Arbuckle TE, Ashley-Martin J, Fraser WD, Fisher M, Bouchard MF, Monnier P, Morisset AS, Ettinger AS, Dodds L.

Environ Res. 2018 Feb;161:554-561. doi: 10.1016/j.envres.2017.12.001.

10.

Genomic Biomarkers Predicting Response to Selective CDK4/6 Inhibition: Progress in an Elusive Search.

Shapiro GI.

Cancer Cell. 2017 Dec 11;32(6):721-723. doi: 10.1016/j.ccell.2017.11.013.

PMID:
29232548
11.

Correlates of Tinder Use and Risky Sexual Behaviors in Young Adults.

Shapiro GK, Tatar O, Sutton A, Fisher W, Naz A, Perez S, Rosberger Z.

Cyberpsychol Behav Soc Netw. 2017 Dec;20(12):727-734. doi: 10.1089/cyber.2017.0279. Epub 2017 Dec 6.

PMID:
29211500
12.

Sensitizing HR-proficient cancers to PARP inhibitors.

Lim E, Johnson SF, Geyer M, Serra V, Shapiro GI.

Mol Cell Oncol. 2017 Mar 3;4(6):e1299272. doi: 10.1080/23723556.2017.1299272. eCollection 2017. No abstract available.

PMID:
29209638
13.

Parents' involvement in the human papillomavirus vaccination decision for their sons.

Perez S, Restle H, Naz A, Tatar O, Shapiro GK, Rosberger Z.

Sex Reprod Healthc. 2017 Dec;14:33-39. doi: 10.1016/j.srhc.2017.08.005. Epub 2017 Aug 24.

PMID:
29195632
14.

Impact of Work-Related Burn Injury on Social Reintegration Outcomes: A Life Impact Burn Recovery Evaluation (LIBRE) Study.

Schneider JC, Shie VL, Espinoza LF, Shapiro GD, Lee A, Acton A, Marino M, Jette A, Kazis LE, Ryan CM; LIBRE Advisory Board.

Arch Phys Med Rehabil. 2017 Nov 26. pii: S0003-9993(17)31383-7. doi: 10.1016/j.apmr.2017.10.022. [Epub ahead of print]

PMID:
29183751
15.

Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study.

Tatar O, Perez S, Naz A, Shapiro GK, Rosberger Z.

Papillomavirus Res. 2017 Dec;4:99-107. doi: 10.1016/j.pvr.2017.11.001. Epub 2017 Nov 8.

16.

U.S. pregnant women's knowledge and attitudes about behavioral strategies and vaccines to prevent Zika acquisition.

Fraiz LD, de Roche A, Mauro C, Catallozzi M, Zimet GD, Shapiro GK, Rosenthal SL.

Vaccine. 2018 Jan 2;36(1):165-169. doi: 10.1016/j.vaccine.2017.11.021. Epub 2017 Nov 20.

PMID:
29157958
17.

Development of Clinical Process Measures for Pediatric Burn Care: Understanding Variation in Practice Patterns.

Kazis LE, Sheridan RL, Shapiro GD, Lee AF, Liang MH, Ryan CM, Schneider JC, Lydon M, Soley-Bori M, Sonis LA, Dore EC, Palmieri T, Herndon D, Meyer W, Warner P, Kagan R, Stoddard FJ, Murphy M, Tompkins RG.

J Trauma Acute Care Surg. 2017 Nov 14. doi: 10.1097/TA.0000000000001737. [Epub ahead of print]

PMID:
29140950
18.

Birth outcomes among First Nations, Inuit and Métis populations.

Sheppard AJ, Shapiro GD, Bushnik T, Wilkins R, Perry S, Kaufman JS, Kramer MS, Yang S.

Health Rep. 2017 Nov 15;28(11):11-16.

19.

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR, Ivanova E, Paweletz CP, Bowden M, Zhou CW, Herter-Sprie GS, Sorrentino JA, Bisi JE, Lizotte PH, Merlino AA, Quinn MM, Bufe LE, Yang A, Zhang Y, Zhang H, Gao P, Chen T, Cavanaugh ME, Rode AJ, Haines E, Roberts PJ, Strum JC, Richards WG, Lorch JH, Parangi S, Gunda V, Boland GM, Bueno R, Palakurthi S, Freeman GJ, Ritz J, Haining WN, Sharpless NE, Arthanari H, Shapiro GI, Barbie DA, Gray NS, Wong KK.

Cancer Discov. 2018 Feb;8(2):216-233. doi: 10.1158/2159-8290.CD-17-0915. Epub 2017 Nov 3.

PMID:
29101163
20.

Long-Term Social Reintegration Outcomes for Burn Survivors With and Without Peer Support Attendance: A Life Impact Burn Recovery Evaluation (LIBRE) Study.

Grieve B, Shapiro GD, Wibbenmeyer L, Acton A, Lee A, Marino M, Jette A, Schneider JC, Kazis LE, Ryan CM; LIBRE Advisory Board.

Arch Phys Med Rehabil. 2017 Oct 31. pii: S0003-9993(17)31328-X. doi: 10.1016/j.apmr.2017.10.007. [Epub ahead of print]

PMID:
29097179
21.

Validation of the vaccine conspiracy beliefs scale.

Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z.

Papillomavirus Res. 2016 Dec;2:167-172. doi: 10.1016/j.pvr.2016.09.001. Epub 2016 Sep 30.

22.

Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours.

Schöffski P, Gordon M, Smith DC, Kurzrock R, Daud A, Vogelzang NJ, Lee Y, Scheffold C, Shapiro GI.

Eur J Cancer. 2017 Nov;86:296-304. doi: 10.1016/j.ejca.2017.09.011. Epub 2017 Oct 20.

23.

Co-responding police-mental health programmes: Service user experiences and outcomes in a large urban centre.

Lamanna D, Shapiro GK, Kirst M, Matheson FI, Nakhost A, Stergiopoulos V.

Int J Ment Health Nurs. 2017 Oct 17. doi: 10.1111/inm.12384. [Epub ahead of print]

PMID:
29044920
24.

Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey.

Shapiro GK, Perez S, Naz A, Tatar O, Guichon JR, Amsel R, Zimet GD, Rosberger Z.

BMJ Open. 2017 Oct 11;7(10):e017814. doi: 10.1136/bmjopen-2017-017814.

25.

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model.

Shapiro G, Bez M, Tawackoli W, Gazit Z, Gazit D, Pelled G.

J Vis Exp. 2017 Sep 28;(127). doi: 10.3791/55928.

PMID:
28994771
26.

Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK.

Shapiro GK, Surian D, Dunn AG, Perry R, Kelaher M.

BMJ Open. 2017 Oct 5;7(10):e016869. doi: 10.1136/bmjopen-2017-016869.

27.

First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors.

Bédard PL, Davies MA, Kopetz S, Juric D, Shapiro GI, Luke JJ, Spreafico A, Wu B, Castell C, Gomez C, Cartot-Cotton S, Mazuir F, Dubar M, Micallef S, Demers B, Flaherty KT.

Cancer. 2018 Jan 15;124(2):315-324. doi: 10.1002/cncr.31044. Epub 2017 Oct 4.

PMID:
28976556
28.

Canadian school-based HPV vaccine programs and policy considerations.

Shapiro GK, Guichon J, Kelaher M.

Vaccine. 2017 Oct 9;35(42):5700-5707. doi: 10.1016/j.vaccine.2017.07.079.

PMID:
28893472
29.

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

Mita MM, Mita AC, Moseley JL, Poon J, Small KA, Jou YM, Kirschmeier P, Zhang D, Zhu Y, Statkevich P, Sankhala KK, Sarantopoulos J, Cleary JM, Chirieac LR, Rodig SJ, Bannerji R, Shapiro GI.

Br J Cancer. 2017 Oct 24;117(9):1258-1268. doi: 10.1038/bjc.2017.288. Epub 2017 Aug 31.

PMID:
28859059
30.

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers.

Hai J, Liu S, Bufe L, Do K, Chen T, Wang X, Ng C, Li S, Tsao MS, Shapiro GI, Wong KK.

Clin Cancer Res. 2017 Nov 15;23(22):6993-7005. doi: 10.1158/1078-0432.CCR-17-1098. Epub 2017 Aug 18.

PMID:
28821559
31.

Primed polymorphonuclear leukocytes from hemodialysis patients enhance monocyte transendothelial migration.

Kliger E, Kristal B, Shapiro G, Chezar J, Sela S.

Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H974-H987. doi: 10.1152/ajpheart.00122.2017. Epub 2017 Aug 4.

PMID:
28778910
32.

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

Engstrom LD, Aranda R, Lee M, Tovar EA, Essenburg CJ, Madaj Z, Chiang H, Briere D, Hallin J, Lopez-Casas PP, Baños N, Menendez C, Hidalgo M, Tassell V, Chao R, Chudova DI, Lanman RB, Olson P, Bazhenova L, Patel SP, Graveel C, Nishino M, Shapiro GI, Peled N, Awad MM, Jänne PA, Christensen JG.

Clin Cancer Res. 2017 Nov 1;23(21):6661-6672. doi: 10.1158/1078-0432.CCR-17-1192. Epub 2017 Aug 1.

PMID:
28765324
33.

Untangling the psychosocial predictors of HPV vaccination decision-making among parents of boys.

Perez S, Tatar O, Gilca V, Shapiro GK, Ogilvie G, Guichon J, Naz A, Rosberger Z.

Vaccine. 2017 Aug 24;35(36):4713-4721. doi: 10.1016/j.vaccine.2017.07.043. Epub 2017 Jul 27.

PMID:
28757059
34.

Introduction: Decision Making With Older Cancer Patients.

Shapiro GR.

Cancer J. 2017 Jul/Aug;23(4):199-200. doi: 10.1097/PPO.0000000000000275. No abstract available.

PMID:
28731940
35.

Age at first febrile seizure correlates with perinatal maternal emotional symptoms.

Thébault-Dagher F, Herba CM, Séguin JR, Muckle G, Lupien SJ, Carmant L, Simard MN, Shapiro GD, Fraser WD, Lippé S.

Epilepsy Res. 2017 Sep;135:95-101. doi: 10.1016/j.eplepsyres.2017.06.001. Epub 2017 Jun 10.

PMID:
28651086
36.

In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs.

Bez M, Sheyn D, Tawackoli W, Avalos P, Shapiro G, Giaconi JC, Da X, David SB, Gavrity J, Awad HA, Bae HW, Ley EJ, Kremen TJ, Gazit Z, Ferrara KW, Pelled G, Gazit D.

Sci Transl Med. 2017 May 17;9(390). pii: eaal3128. doi: 10.1126/scitranslmed.aal3128.

37.

Building Bridges Using the Shriners Hospitals for Children/American Burn Association Burn Outcome Questionnaires to Follow Teenagers and Young Adults Across the Age Spans.

Kaat AJ, Chen L, Kazis LE, Lee AF, Shapiro GD, Sheridan RL, Ryan CM, Schneider JC.

J Burn Care Res. 2017 May 4. doi: 10.1097/BCR.0000000000000566. [Epub ahead of print]

PMID:
28481758
38.

Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.

Ben-Ami E, Barysauskas CM, Solomon S, Tahlil K, Malley R, Hohos M, Polson K, Loucks M, Severgnini M, Patel T, Cunningham A, Rodig SJ, Hodi FS, Morgan JA, Merriam P, Wagner AJ, Shapiro GI, George S.

Cancer. 2017 Sep 1;123(17):3285-3290. doi: 10.1002/cncr.30738. Epub 2017 Apr 25.

39.

A Multiple Streams analysis of the decisions to fund gender-neutral HPV vaccination in Canada.

Shapiro GK, Guichon J, Prue G, Perez S, Rosberger Z.

Prev Med. 2017 Jul;100:123-131. doi: 10.1016/j.ypmed.2017.04.016. Epub 2017 Apr 20. Review.

PMID:
28435081
40.

Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach.

Sun W, O'Dwyer PJ, Finn RS, Ruiz-Garcia A, Shapiro GI, Schwartz GK, DeMichele A, Wang D.

J Clin Pharmacol. 2017 Sep;57(9):1159-1173. doi: 10.1002/jcph.902. Epub 2017 Apr 18.

PMID:
28419480
41.

The evolving role of cyclin-dependent kinase inhibitors in cancer management.

Shapiro GI.

Clin Adv Hematol Oncol. 2017 Mar;15(3):174-177. No abstract available.

PMID:
28398270
42.

Proceedings From the 2016 Mid-Year Meeting of the Committee for Tactical Emergency Casualty Care (C-TECC) and Committee Updates.

Shapiro G, Tang N, Kamin R, Smith R.

J Spec Oper Med. Spring 2017;17(1):149-151. No abstract available.

PMID:
28285494
43.

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.

Kristeleit R, Shapiro GI, Burris HA, Oza AM, LoRusso P, Patel MR, Domchek SM, Balmaña J, Drew Y, Chen LM, Safra T, Montes A, Giordano H, Maloney L, Goble S, Isaacson J, Xiao J, Borrow J, Rolfe L, Shapira-Frommer R.

Clin Cancer Res. 2017 Aug 1;23(15):4095-4106. doi: 10.1158/1078-0432.CCR-16-2796. Epub 2017 Mar 6.

PMID:
28264872
44.

The authors respond to "Supporting the call for a gender-neutral human papillomavirus vaccination in Canada".

Shapiro GK, Perez S, Rosberger Z.

CMAJ. 2017 Jan 23;189(3):E119. doi: 10.1503/cmaj.732630. No abstract available.

45.

Maternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight.

Ashley-Martin J, Dodds L, Arbuckle TE, Bouchard MF, Fisher M, Morriset AS, Monnier P, Shapiro GD, Ettinger AS, Dallaire R, Taback S, Fraser W, Platt RW.

Am J Epidemiol. 2017 Feb 1;185(3):185-193. doi: 10.1093/aje/kww213.

46.

A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone.

Cleary JM, Rosen LS, Yoshida K, Rasco D, Shapiro GI, Sun W.

Invest New Drugs. 2017 Apr;35(2):189-197. doi: 10.1007/s10637-016-0409-9. Epub 2017 Jan 23.

47.

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.

Daud A, Kluger HM, Kurzrock R, Schimmoller F, Weitzman AL, Samuel TA, Moussa AH, Gordon MS, Shapiro GI.

Br J Cancer. 2017 Feb 14;116(4):432-440. doi: 10.1038/bjc.2016.419. Epub 2017 Jan 19.

48.

Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patients.

Beberashvili I, Sinuani I, Azar A, Shapiro G, Feldman L, Doenyas-Barak K, Stav K, Efrati S.

BMC Nephrol. 2017 Jan 18;18(1):29. doi: 10.1186/s12882-017-0442-8.

49.

Previous pregnancy outcomes and subsequent pregnancy anxiety in a Quebec prospective cohort.

Shapiro GD, Séguin JR, Muckle G, Monnier P, Fraser WD.

J Psychosom Obstet Gynaecol. 2017 Jun;38(2):121-132. doi: 10.1080/0167482X.2016.1271979. Epub 2017 Jan 12.

PMID:
28079434
50.

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.

Shapiro GI, Vaishampayan UN, LoRusso P, Barton J, Hua S, Reich SD, Shazer R, Taylor CT, Xuan D, Borghaei H.

Invest New Drugs. 2017 Jun;35(3):315-323. doi: 10.1007/s10637-016-0419-7. Epub 2017 Jan 9.

Supplemental Content

Loading ...
Support Center